Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven A Eschrich

Showing results (31-40 of 86) with videos related to

Pageof 9
Sort By:
The American Journal of Pathology|August 14, 2016
Knockdown of CSE1L Gene in Colorectal Cancer Reduces Tumorigenesis in VitroJose M Pimiento, Kevin G Neill, Evita Henderson-Jackson, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|August 10, 2020
LC-HRMS of derivatized urinary estrogens and estrogen metabolites in postmenopausal womenLancia N F Darville, Jayden K Cline, Carrie Rozmeski, et al.
Bioinformatics (Oxford, England)|June 15, 2019
GMSimpute: a generalized two-step Lasso approach to impute missing values in label-free mass spectrum analysisQian Li, Kate Fisher, Wenjun Meng, et al.
Cancer Research Communications|February 11, 2025
Evaluating the Radiation Sensitivity Index and 12-Chemokine Gene Expression Signature for Clinical Use in a CLIA LaboratoryAnders E Berglund, John Puskas, Sean J Yoder, et al.
The Lancet. Oncology|August 7, 2021
Pan-cancer prediction of radiotherapy benefit using genomic-adjusted radiation dose (GARD): a cohort-based pooled analysisJacob G Scott, Geoffrey Sedor, Patrick Ellsworth, et al.
Proteomes|February 4, 2017
Activity-Based Proteomics Reveals Heterogeneous Kinome and ATP-Binding Proteome Responses to MEK Inhibition in KRAS Mutant Lung CancerJae-Young Kim, Paul A Stewart, Adam L Borne, et al.
Oncotarget|July 1, 2021
Correction: Transforming growth factor β-induced epithelial-to-mesenchymal signature predicts metastasis-free survival in non-small cell lung cancerEdna Gordian, Eric A Welsh, Nicholas Gimbrone, et al.
Plos One|November 6, 2015
A Pilot Proteogenomic Study with Data Integration Identifies MCT1 and GLUT1 as Prognostic Markers in Lung AdenocarcinomaPaul A Stewart, Katja Parapatics, Eric A Welsh, et al.
Oncotarget|February 21, 2019
Transforming growth factor β-induced epithelial-to-mesenchymal signature predicts metastasis-free survival in non-small cell lung cancerEdna Gordian, Eric A Welsh, Nicholas Gimbrone, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 22, 2022
Characterization of Epigenomic Alterations in HPV16+ Head and Neck Squamous Cell CarcinomasAnders Berglund, Clarisse Muenyi, Erin M Siegel, et al.
Pageof 9

Showing results (31-40 of 86) with videos related to

Sort By:
Pageof 9
The American Journal of Pathology|August 14, 2016
Knockdown of CSE1L Gene in Colorectal Cancer Reduces Tumorigenesis in VitroJose M Pimiento, Kevin G Neill, Evita Henderson-Jackson, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|August 10, 2020
LC-HRMS of derivatized urinary estrogens and estrogen metabolites in postmenopausal womenLancia N F Darville, Jayden K Cline, Carrie Rozmeski, et al.
Bioinformatics (Oxford, England)|June 15, 2019
GMSimpute: a generalized two-step Lasso approach to impute missing values in label-free mass spectrum analysisQian Li, Kate Fisher, Wenjun Meng, et al.
Cancer Research Communications|February 11, 2025
Evaluating the Radiation Sensitivity Index and 12-Chemokine Gene Expression Signature for Clinical Use in a CLIA LaboratoryAnders E Berglund, John Puskas, Sean J Yoder, et al.
The Lancet. Oncology|August 7, 2021
Pan-cancer prediction of radiotherapy benefit using genomic-adjusted radiation dose (GARD): a cohort-based pooled analysisJacob G Scott, Geoffrey Sedor, Patrick Ellsworth, et al.
Proteomes|February 4, 2017
Activity-Based Proteomics Reveals Heterogeneous Kinome and ATP-Binding Proteome Responses to MEK Inhibition in KRAS Mutant Lung CancerJae-Young Kim, Paul A Stewart, Adam L Borne, et al.
Oncotarget|July 1, 2021
Correction: Transforming growth factor β-induced epithelial-to-mesenchymal signature predicts metastasis-free survival in non-small cell lung cancerEdna Gordian, Eric A Welsh, Nicholas Gimbrone, et al.
Plos One|November 6, 2015
A Pilot Proteogenomic Study with Data Integration Identifies MCT1 and GLUT1 as Prognostic Markers in Lung AdenocarcinomaPaul A Stewart, Katja Parapatics, Eric A Welsh, et al.
Oncotarget|February 21, 2019
Transforming growth factor β-induced epithelial-to-mesenchymal signature predicts metastasis-free survival in non-small cell lung cancerEdna Gordian, Eric A Welsh, Nicholas Gimbrone, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 22, 2022
Characterization of Epigenomic Alterations in HPV16+ Head and Neck Squamous Cell CarcinomasAnders Berglund, Clarisse Muenyi, Erin M Siegel, et al.
Pageof 9